Tomonori Morimoto

5PUBLICATIONS
17CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 15, 2026
Involvement of tyrosine phosphatase PTPROt in acquired resistance to FGFR inhibitor therapy in colorectal cancer.

|Oct 31, 2025
Comprehensive Colorectal Cancer Stem Cell Transcriptomic Signatures That Can Predict Patient Prognostic Outcomes.

Fumihiko Kakizaki, Hiroyuki Miyoshi, Takehito Yamamoto

|Dec 12, 2024
Dual inhibition of oxidative phosphorylation and glycolysis exerts a synergistic antitumor effect on colorectal and gastric cancer by creating energy depletion and preventing metabolic switch.

Yuki Aisu, Nobu Oshima, Fuminori Hyodo

|May 20, 2023
Novel and efficient method for culturing patient-derived gastric cancer stem cells.

Tomonori Morimoto, Yukitoshi Takemura, Takemitsu Miura

|Feb 13, 2023
Efficacious Combination Drug Treatment for Colorectal Cancer That Overcomes Resistance to KRAS G12C Inhibitors.

Hiroyuki Matsubara, Hiroyuki Miyoshi, Fumihiko Kakizaki

Pageof 1

Frequent Collaborators

4 joint publications

Takehito Yamamoto

4 joint publications

Makoto Mark Taketo

3 joint publications

Hiroyuki Miyoshi

3 joint publications

Fumihiko Kakizaki